Adagene_RGB.jpg
Adagene Inc. Announces Pricing of Initial Public Offering
February 09, 2021 09:00 ET | Adagene Inc.
SAN FRANCISCO, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene" or the "Company") (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to...